0000882796 2026-08-04 2026-08-04 0000882796 1 2026-08-04 2026-08-04 iso4217:USD pure shares S-8 S-8 EX-FILING FEES 0000882796 BIOCRYST PHARMACEUTICALS INC N/A false S-8 BIOCRYST PHARMACEUTICALS INC Equity Common Stock, $0.01 par value true 7000000 9.09 63630000.00 0.0001381 8787.30 63630000.00 8787.30 0.00 8787.30 This Registration Statement on Form S-8 covers (i) 7,000,000 shares of Common Stock authorized to be issued under the Stock Incentive Plan (as amended and restated as of April 20, 2026) and (ii) pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the "Securities Act"), any additional shares of Common Stock which become issuable by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without the receipt of consideration which results in an increase in the number of the Registrant's outstanding shares of Common Stock. The proposed maximum offering price per unit is estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) under the Securities Act, based on the average of the high and low prices of the Registrant's Common Stock on July 31, 2026, as reported on The Nasdaq Global Select Market.